Healthcare Services M&A Advisory
Clinic networks, dental groups, diagnostics, home health, and healthcare operations. We advise clinical founders and shareholders on exits that protect what they built, and acquirers on deals where retention is the return. $10m to $100m+ in enterprise value.
LePrince Group advises on mid-market M&A in healthcare services, including clinic networks, dental groups, diagnostics, and home health, on both the sell-side and buy-side, globally.
Consolidation with consequences.
Healthcare services, clinic networks, dental groups, diagnostics, home health, and the operations businesses around them, has consolidated faster than almost any sector in the mid-market. The buyers are sophisticated, the structures are complex, and the gap between a good outcome and a regretted one is wider here than anywhere else we work.
That is the honest context. Clinical businesses are not just cash flows; they are clinicians, patients, and a culture that determines whether the value survives the transaction. We advise accordingly.
The value drivers in a healthcare services business.
Healthcare deals are priced on durability: of clinicians, of payors, and of compliance.
Clinician retention and alignment
The asset walks out the door every evening. Retention history, employment structures, and post-close alignment mechanics are priced before anything else.
Payor mix and revenue integrity
The balance of payor sources, reimbursement durability, and clean, defensible coding and billing. Revenue that survives an audit is revenue a buyer will pay for.
Same-store growth and de novo capability
Buyers underwrite the engine, not just the estate: organic growth in existing sites and a proven ability to open or integrate new ones.
Compliance infrastructure
Licensing, referral rules, clinical governance, documentation. In this sector compliance is not overhead; it is the deal's foundation.
The right buyer matters as much as the number.
Clinical founders have heard the stories: groups sold on a headline number where the equity component was opaque, the earnout never paid, and the practice they built stopped feeling like theirs. We structure against those outcomes. That means earnouts designed to be achievable, equity components you can actually evaluate, and acquirers vetted for clinical culture and integration record, not just the cheque.
And we say plainly what we believe the business is worth before taking the mandate, including how the structure, not just the headline, determines what you actually receive.
Diligence that protects the thesis and the clinic.
For acquirers building healthcare platforms, we originate against a clear clinical and geographic thesis, run diligence across revenue integrity, clinician contracts, and compliance, and structure transactions that keep clinicians aligned after close, because in this sector retention is the return.
Frequently asked questions.
What multiple does a healthcare services business sell for?
It varies widely with scale, payor mix, and clinician alignment, and the headline multiple often matters less than the structure: cash at close versus equity and earnout components. We assess both the number and the structure before taking a mandate, and we tell you what we believe you will actually receive.
Who buys healthcare services companies?
Private equity-backed platforms, strategic operators, and family offices with long-hold healthcare strategies. The buyer landscape is deep but uneven; vetting the acquirer is as important as running the auction.
How should a clinical founder evaluate an equity rollover or earnout?
Treat both as part of the price you may or may not receive. We model earnout achievability against the buyer's own plan, scrutinize what the rolled equity is actually worth, and negotiate protections so the structure works for the seller, not only the spreadsheet.
How do you keep a clinic sale confidential?
Tight buyer lists, staged disclosure, anonymized marketing materials, and management of when clinicians and staff learn of the process. Confidentiality discipline is built into every healthcare mandate.
How long does it take to sell a healthcare services business?
Typically six to twelve months, with regulatory and licensing steps sometimes extending the close. Early preparation of compliance and revenue documentation is the biggest accelerant.
You won't find our deals online. That is the point.
We do not publicise mandates, name clients, or announce transactions. The best outcomes are reached quietly, and confidentiality protects the seller, the process, and the price.
Confidential by default
A sale is the client's business, not our marketing. The market learns only what serves the client.
Selective by mandate
We take a limited number of companies and turn the rest down. Selectivity is the product, not a constraint on it.
Vetted and verified
If we represent a company, it is proven to be one of the best in its category, with a clear opportunity for the right buyer.
Selling or acquiring a healthcare services business?
Every conversation starts with the LePrince Read: an honest, evidence-based view of what the business is worth, what the structure really pays, and whether it would sell. Confidential, and yours to keep.
We take a limited number of mandates. Request a conversation if:
- Your company is in the $10m to $100m+ enterprise value range
- You operate in or adjacent to our four sectors
- You want an honest read, not a flattering one